In the latest quarter, 7 analysts provided ratings for Eli Lilly LLY +1.30% Get Free Report , showcasing a mix of bullish and ...

The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should see earnings gains through the end of the decade.

Eli Lilly reported impressive data at the recent American Diabetes Association ('ADA') conference. Its robust pipeline will ...

The Vital Role of Protein Synthesis in Modern Biotechnology and Its Impact on Chronic Disease Treatment, Technological Advances, and Market Growth" BOSTON ...

BCC Research announces the release of its "2024 Protein Synthesis Research Review," which provides comprehensive insights ...

Stock indexes are mixed in midday trading Tuesday, coming off a broad sell-off following the Trump administration’s decision ...

Top 10 most valuable companies in 2025—see which global giants are leading the market with innovation, revenue, and impact.

Union momentum grows in Ireland’s €100bn pharma sector as Trump’s tariff threats and weak labour laws fuel worker unrest ...

Bengaluru: HealthCare Global Enterprises (HCG), one of Bengaluru’s leading cancer treatment hospitals, has come under serious ...

Eli Lilly and Company (NYSE:LLY) is one of the 13 best blue-chip stocks to buy, according to analysts. On June 30, RBC ...

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

Camurus (NASDAQ STO: CAMX) today announced that the European Commission (EC) has granted Oczyesa®, octreotide subcutaneous depot, ...